How to buy CardieX shares
Own CardieX shares in just a few minutes.
CardieX Limited is a medical devices business based in Australia. CardieX shares (CDX) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. CardieX has a trailing 12-month revenue of around $5.1 million.
How to buy shares in CardieX
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for CardieX. Find the share by name or ticker symbol: CDX. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until CardieX reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price of $N/A, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of CardieX. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
CardieX share priceUse our graph to track the performance of CDX stocks over time.
CardieX shares at a glance
|52-week range||AUDA$0.014 - AUDA$0.065|
|50-day moving average||AUDA$0.0528|
|200-day moving average||AUDA$0.0306|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||AUDA$-0.005|
Standard brokerage - Australian shares
Share Trading Account Offer
Competitive broker fees on Australian and international shares
- Brokerage - AU shares: From AUD 5 or 0.05%
- Brokerage - US shares: USD 0
- Sign-up process: Instant
- Support - After hours: Yes
Important: Share trading carries risk of capital loss.
Compare share trading platforms
Is it a good time to buy CardieX stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|Revenue TTM||$5.1 million|
|Gross profit TTM||$4.4 million|
|Return on assets TTM||-17.5%|
|Return on equity TTM||-51.76%|
|Market capitalisation||$41.9 million|
TTM: trailing 12 months
CardieX share dividends
We're not expecting CardieX to pay a dividend over the next 12 months.
CardieX share price volatility
Over the last 12 months, CardieX's shares have ranged in value from as little as $0.014 up to $0.065. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while CardieX's is 2.1578. This would suggest that CardieX's shares are significantly more volatile than the average for this exchange and represent a higher risk.
CardieX Limited designs, manufactures, and markets medical devices for use in cardiovascular health management in the Americas, Europe, and the Asia Pacific. The company develops, markets, and distributes medical technologies that measure patient risk for hypertension, cardiovascular disease (CVD), and other related vascular disorders. It also provides TeleHealth Services, which provides digital, e-commerce, and mobile tools for patients to connect online with health coaches. The company offers its devices and services to hospitals, clinics, research institutions and pharmaceutical companies. CardieX Limited has a strategic collaboration with Blumio Inc. to develop wearable sensor; and a joint development agreement with inHealth to develop hypertension and cardiovascular programs for the products. The company was formerly known as AtCor Medical Holdings Limited and changed its name to CardieX Limited in June 2018. CardieX Limited was founded in 1994 and is headquartered in Sydney, Australia.
Frequently asked questions
Ask an Expert